Temozolomide Generics - Manufacturers & Suppliers
Temodar(US), Temodal (EU)
| Product/Composition:- | Temozolomide |
|---|---|
| Strength:- | Capsule( 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg); Powder( 100 mg/vial) |
| Form:- | Capsule and Powder for reconstitution |
| Reference Brands:- | Temodar(US), Temodal (EU) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
emozolomide (Temodar/Temodal) is an oral chemotherapy drug used to treat glioblastoma and anaplastic astrocytoma. Approved in the US and EU, it’s available in 5–250 mg capsules and 100 mg IV form. Trusted by oncology specialists, it offers high bioavailability and compliance. Ideal for B2B pharma sourcing, licensing, or bulk supply.
Temozolomide (Temodar/Temodal) is a potent oral alkylating chemotherapy agent used in the treatment of glioblastoma multiforme and anaplastic astrocytoma. Approved by the FDA (as Temodar) and EMA (as Temodal), it is available in capsule strengths of 5 mg to 250 mg and as a 100 mg injectable vial for IV use. Widely used in neuro-oncology protocols, Temozolomide offers excellent bioavailability and treatment compliance. Multiple generic versions are available from trusted global manufacturers. Ideal for pharmaceutical B2B partners in the US and EU seeking reliable oncology portfolio expansion. Contact us for bulk API supply, licensing, or third-party manufacturing.